When Should Medical Device Companies Start Thinking About Automation?
A common question from medical device startups is:
“When should we start thinking about automation?”
Many teams assume the answer is simple: once production volume increases.
In reality, automation strategy should begin much earlier—during product design and process development.
That does not mean every early-stage company needs to purchase automated equipment right away. In many cases, manual builds are the right choice during prototyping, feasibility work, and early clinical production.
But the decisions made during those early stages can determine whether future automation is straightforward, affordable, and scalable—or whether it becomes a major redesign effort later.
Automation Is a Design Decision, Not Just a Manufacturing Decision
Automation is often viewed as something that happens after a product is fully designed and ready for production.
By that point, many of the most important decisions have already been made.
Part geometry, material selection, assembly sequence, tolerances, inspection methods, product handling, and process flow all influence whether a product can be automated efficiently.
If those factors are not considered early, a company may discover that its product is difficult to load, orient, assemble, inspect, test, package, or trace in an automated process.
That can lead to expensive rework at the exact moment a company is trying to scale.
The most successful medical device teams treat automation as part of the product-development strategy—not as a last-minute manufacturing upgrade.
What Does It Mean to Design with Automation in Mind?
Designing with future automation in mind does not require locking in a machine concept before the device is mature.
It means making informed product and process decisions that preserve future options.
Early automation planning may include evaluating:
Part geometry and orientation
Material behavior during handling and assembly
Critical tolerances and dimensional variation
Component presentation and feeding requirements
Assembly sequence and motion complexity
Manual steps that may be difficult to repeat
Inspection requirements and measurement capability
Traceability and data-collection needs
Test methods and process controls
Packaging, labeling, and downstream handling
Anticipated production volume and takt-time expectations
Quality risks that could be reduced through automation
A component that works well in a hand-built prototype may be difficult for a robotic system to pick, place, inspect, or assemble repeatedly.
A manual process may appear simple at low volume but introduce excessive variation, labor cost, ergonomics concerns, or quality risk as demand grows.
The earlier these issues are identified, the easier they are to address.
Why Waiting Too Long Creates Risk
When automation is considered only after a design is frozen, teams may face difficult tradeoffs.
They may need to redesign parts, change materials, modify tolerances, alter the assembly process, add features for handling or inspection, or invest in more complex custom equipment than originally planned.
Late automation decisions can lead to:
Higher equipment costs
Longer development timelines
More complex machine design
Product redesigns during manufacturing transfer
Increased validation effort
Delays in scaling production
Reduced manufacturing flexibility
Higher labor content and production cost
Inconsistent quality or inspection capability
Limited ability to meet future demand
For MedTech companies, these impacts can extend beyond operations. Manufacturing changes can also affect verification, validation, risk management, regulatory documentation, supplier planning, and commercialization timing.
Manual Production Can Still Be the Right First Step
Early-stage companies do not need to automate every process immediately.
Manual assembly can be valuable when volumes are low, the product is still evolving, or the team is learning how the process behaves in real production conditions.
Manual production can help teams:
Build and evaluate early prototypes quickly
Support feasibility and clinical studies
Learn which assembly steps are most challenging
Identify process variation and quality risks
Gather cycle-time and labor-content data
Improve product and process design before investing in capital equipment
Define the right requirements for future automation
The key is to use manual production intentionally.
Rather than treating manual assembly as a temporary workaround, use it as a learning phase that informs the long-term manufacturing strategy.
The Best Time to Start the Conversation
The best time to begin thinking about automation is when the team is making decisions about product architecture, component design, and assembly methods.
That conversation should happen early enough that product and manufacturing decisions can influence one another.
For example, automation should be considered during:
Concept Development
At the concept stage, teams can begin asking whether the product will require complex assembly, precision handling, repetitive manual work, high-volume production, specialized inspection, or detailed traceability.
These early questions help identify where automation may create future value.
Prototype Development
As prototypes evolve, teams can assess how parts are handled, assembled, inspected, and tested. This is a good time to identify features that may create challenges for feeders, robotics, fixtures, vision systems, or process controls.
Feasibility and Preclinical Work
Feasibility, cadaver, animal, and early clinical work often reveal important insights about device performance and workflow. Those findings can affect the final design, including features that may impact manufacturability and automation.
Process Development
Once the product begins to stabilize, teams can develop a more detailed manufacturing strategy. This may include manual workstations, semi-automated processes, custom fixtures, inspection systems, equipment concepts, or a phased automation roadmap.
Manufacturing Transfer
By the time a product reaches manufacturing transfer, the team should have a clear understanding of which processes will remain manual, which may be semi-automated, and which are strong candidates for full automation as demand grows.
Automation Should Be Driven by Business and Product Needs
Not every process should be automated.
A strong automation strategy considers the full business case, including:
Expected annual production volume
Product lifecycle and forecasted demand
Labor content and operating cost
Quality and process-variation risks
Complexity of the assembly process
Capital investment requirements
Regulatory and validation impact
Product maturity and likelihood of future design changes
Supplier capability
Factory space and production flow
Required throughput, yield, and traceability
The right answer may be manual assembly, selective automation, semi-automated stations, or a fully integrated production line.
The goal is not automation for its own sake.
The goal is to create a manufacturing system that supports quality, scalability, cost control, reliability, and commercial growth.
Building an Automation Roadmap
A practical automation roadmap can help MedTech companies avoid both extremes: investing in too much automation too early or delaying automation until the product is difficult to scale.
A strong roadmap may include:
Product and process assessment
Design-for-manufacturability review
Automation-readiness evaluation
Manual-process learning plan
Process-risk and variability analysis
Throughput and capacity modeling
Inspection and traceability strategy
Supplier and equipment-partner involvement
Phased capital-equipment plan
Manufacturing-transfer milestones
Future automation triggers based on volume, cost, quality, or capacity
This approach allows teams to make smart investments as the product matures.
Automation Supports Scale—When It Is Considered Early
For medical device companies, automation can improve repeatability, quality, traceability, throughput, and cost efficiency.
But the greatest value often comes from early planning—not from the equipment itself.
The more a product is designed with manufacturing and automation in mind, the more options the company has as it moves toward commercialization.
At Birch Design, we help medical device organizations align product development, manufacturing strategy, automation planning, and commercialization readiness from the earliest stages of development.
Building a medical device and evaluating how it will scale? Birch Design helps teams develop practical automation strategies that support quality, growth, and efficient production.